JPM
JPMorgan Chase & Co.
JPM has lower modeled downside risk, despite its lower overall score.
KINS
Kingstone Companies, Inc.
KINS has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
KINS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
KINS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like KINS.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
KINS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7x | $20.56 | -12% |
| Current | 7.9x | $23.23 | — |
| Forward | 8x | $23.23 | — |
| Fair | 11x | $30.94 | +33% |
| Expensive | 26x | $77.02 | +232% |
Historical ranges are pointers, not guarantees.
KINS has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over KINS on the outlook, with more favorable profitability expectations.
KINS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for KINS, but weaker profitability.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
KINS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.90 | -1% |
| Q3 2026 | $2.93 | +31% |
| Q2 2026 | $2.48 | +22% |
| Q1 2026 | $2.21 | +36% |
| Q4 2025 | $2.88 | +95% |
| Q3 2025 | $2.23 | +69% |
| Q2 2025 | $2.04 | +364% |
| Q1 2025 | $1.63 | +8050% |
| Q4 2024 | $1.48 | +$2.05 |
KINS's earnings per share have climbed steadily: $2.93 over the past year, up 31% from the year before, and higher year over year for 14 quarters in a row.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over KINS on profitability, with a higher operating margin.
KINS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $67.5M | +21% |
| Q2 2026 | $65.9M | +26% |
| Q1 2026 | $59.8M | +18% |
| Q4 2025 | $56.4M | +34% |
| Q3 2025 | $55.7M | +36% |
| Q2 2025 | $52.3M | +43% |
| Q1 2025 | $50.5M | +41% |
| Q4 2024 | $42.1M | +15% |
KINS has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 33% | +8.4 points |
| Q2 2026 | 30% | +2.5 points |
| Q1 2026 | -12% | -22 points |
| Q4 2025 | 33% | +17 points |
| Q3 2025 | 25% | +2.3 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 9.3% | +4.3 points |
| Q4 2024 | 16% | +5.2 points |
KINS's operating margin was 33% last quarter, up 8.4 points from the same quarter a year ago, near the top of its range since 2019.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
KINS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21M | -17% |
| Q2 2026 | $27.8M | +220% |
| Q1 2026 | $7.9M | -54% |
| Q4 2025 | $22.1M | -1.4% |
| Q3 2025 | $25.3M | +20% |
| Q2 2025 | $8.7M | +31% |
| Q1 2025 | $17M | +206% |
| Q4 2024 | $22.4M | +462% |
KINS has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over KINS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
KINS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +44.5K shares |
| 1 year | +0.8% | +115K shares |
| 3 years | +37% | +4M shares |
| 5 years | +40% | +4.2M shares |
| Available history | +37% | +3.9M shares |
KINS has 15M diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q4 2021 | — |
| Q3 2021 | $631,548 |
| Q2 2021 | $974,135 |
| Q1 2021 | $65,915 |
| Q4 2020 | $381,543 |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
KINS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
KINS has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
KINS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.0 | Overbought |
| Stochastic | 87.0 | Overbought |
KINS's weekly RSI is 74 (overbought) and its Stochastic is 87 (overbought).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
KINS PE vs Financial Services Sector
| Metric | KINS | Sector median | Relative |
|---|---|---|---|
| PE | 7.9x | 13x | 39% below |
| PE % | 33 | 63 | 30 pts below |
KINS has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
KINS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.7 | 18% above |
| 20 week MA | $19.8 | 18% above |
| 50 week MA | $17.5 | 33% above |
| 100 week MA | $16.6 | 40% above |
| 200 week MA | $10.4 | 124% above |
KINS has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
KINS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.36 | $6.52 | -11% |
| 2021 | $6.52 | $4.99 | -23% |
| 2022 | $4.99 | $1.41 | -72% |
| 2023 | $1.41 | $2.13 | +51% |
| 2024 | $2.13 | $15.4 | +624% |
| 2025 | $15.4 | $17.3 | +12% |
| 2026 YTD | $17.3 | $23.2 | +34% |
KINS has the edge over JPM on returns for 2026, with the stronger performance.